Dec 17 (Reuters) – Medline will debut on the Nasdaq later on Wednesday after the U.S. medical supply giant raised $6.26 billion in the biggest global initial public offering of 2025, capping a strong year for new listings and fueling optimism for 2026.
Sign up here.
U.S. IPO activity has stayed resilient in 2025, shrugging off the impact of market volatility in April, fueled by President Donald Trump’s sweeping tariffs, as well as the longest government shutdown.
ROBUST BUSINESS BUT TARIFFS A CONCERN
Northfield, Illinois-based Medline, which was founded in 1966 by brothers Jon and Jim Mills, is a key manufacturer and distributor of medical supplies such as surgical kits, gloves, and gowns used by hospitals worldwide.
Medline set for hotly anticipated debut after 2025’s biggest IPO
